Furthermore, GPR109A has also been reported to be silenced in colon cancer in humans and in a mouse model and to induce apoptosis in colon cancer cells when expression is re-established, highlighting the potential role of microbial metabolites in mediating the role as a tumour suppressor in the human colon [172,174]. This evidence concerns the gene HCAR2 and colonic neoplasm.